USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
26 Oct 2022 | 09:00 AM GMT

How to Sell DTx to Life Sciences Companies?

Anchored by:

Aahuti Rai
NED, Advisor & Venture Partner
FOUR POINTS HEALTH | CONDUIT CONNECT

Participants:

Aahuti Rai NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Aahuti Rai
NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Jock Thompson CEOHyduro, Inc.
Jock Thompson
CEOHyduro, Inc.
Jyri Yli-Villamo Head of Pharma Global Strategic PartnershipsKaiku Health
Jyri Yli-Villamo
Head of Pharma Global Strategic PartnershipsKaiku Health
Louise O'Mahony Head of Customer SuccessEXi
Louise O'Mahony
Head of Customer SuccessEXi
Malin Johansson Vice PresidentNovo Nordisk
Malin Johansson
Vice PresidentNovo Nordisk
Philipp Unruh Digital Product ManagerBayer AG
Philipp Unruh
Digital Product ManagerBayer AG
Piotr Sokolowski Chief Medtech StrategistS3 Connected Health
Piotr Sokolowski
Chief Medtech StrategistS3 Connected Health

About this Meeting

Over the last few years, partnerships between digital therapeutics (DTx) and Life Sciences companies have grown exponentially. The number of DTx companies pitching to Life Sciences companies has increased and their requirements are higher, making it harder for DTx startups to stand out from the crowd.  

In times of market growth and high competitiveness, how can DTx companies sell their products to Life Sciences companies? Join us for this interesting conversation on:  

  • With so many possible partners, being precise is important for an efficient partner search and selection. Their products, therapeutic areas, company vision and objectives are the starters to search for the best ‘buyer’. How can DTx companies choose the right company to sell their product?  
  • How to best position a DTx solution to get the buy-in of Life Sciences companies? 
  • The volatility within the pharma industry doesn't allow you to move on - the turnout of people is high, how can you find the right champions inside the company then?  
  • Standards are becoming higher, how can new startups meet those higher standards and  stand out from the crowd? 
  • When selling your DTx solution to a Life Sciences company, how to make sure you will have a long-term partnership rather than just a short-term commercial deal?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.